榴莲视频

Latest Medical News

FDA: No Clear Sign of Harm With Olmesartan in Diabetics

The evidence linking use of the angiotensin II receptor blocker (ARB) olmesartan in patients with diabetes and increased cardiovascular risk is not conclusive, according to a completed FDA safety review.

Obesity, T2D May Alter Gut Bacteria

CHICAGO -- The portfolio of gut bacteria in patients with obesity and type 2 diabetes may look different from that of healthy people, researchers reported here.

Learning How to Deal With Egos

Managing physicians need to take egos -- including their own -- into account when resolving conflicts among staff, says consultant Rosemarie Nelson.

PDE4 Inhibitor May Help PCOS Patients Slim Down

CHICAGO -- Adding the phosphodiesterase-4 inhibitor roflumilast to metformin may help obese women with polycystic ovarian syndrome shed pounds and improve other metabolic markers, researchers reported.

Heart Risk Higher in Sjogren's Patients

PARIS -- Patients with Sjogren's syndrome had more than double the heart attack risk seen in the general population, a researcher reported here.

Orencia Combo Tops in Early, Severe RA

PARIS -- In a study of patients with poor-prognosis early rheumatoid arthritis, more patients treated with abatacept (Orencia) plus methotrexate were in remission at 1 year than were those on methotrexate alone, a researcher reported here.

AMA Highlights: VA, Cheerleaders, and Guns

CHICAGO -- Wrapping up a full agenda, the AMA agrees cheerleading is a sport, doctors outside the VA need to pitch in to help care for veterans, and e-cigarettes need to be regulated.

AMA Clamps Down on MOC, But Punts on Gun Regs

CHICAGO -- The AMA鈥檚 House of Delegates drew the line on this year's hot button topic -- maintenance of certification (MOC), saying it should not be mandatory, nor should it be a condition of licensure.

AMA Agrees to Recharge Advocacy

CHICAGO -- The AMA will bolster their political advocacy efforts, recognize presurgical transgender birth certificates, and support insurance to cover young pregnant women and newborns, their House of Delegates voted here.

Not Your Parent's School Nurse

Schools and health systems are forming partnerships to better integrate their services, and some school health professionals are gaining access to students' electronic health records.

AMA Mulls Gun Violence CME

CHICAGO -- As the AMA's House of Delegates was meeting in a downtown hotel here, 29 local residents were shot and four killed within a 10-mile radius.

Give Me That Old Time AMA

After an absence of a few years, I find myself back in Chicago for the AMA's annual meeting and discover that not much has changed.

ASCO: Myeloma Study Results Inconclusive

CHICAGO -- A trial comparing two immunomodulatory regimens for myeloma failed to demonstrate noninferiority for the newer drug.

Victoza Accused of Causing Pancreatitis

The watchdog group Public Citizen has conducted its own analysis of FDA adverse event reports and concluded that the type 2 diabetes drug liraglutide(Victoza) likely causes pancreatitis, the group said.

Lethal Injections, MOC, and E-Cigs on AMA Agenda

The American Medical Association is being asked to strengthen its ethical stance on physician participation in execution by extending its ban on doctors participating to include all health professionals.

ASCO: Combo Extends PFS in Relapsed Myeloma

CHICAGO -- Progression-free survival in relapsed/refractory myeloma increased significantly in patients treated with a three-drug regimen that included panobinostat versus a two-drug regimen, a randomized trial showed.

ASCO: Targeting PD-1 Works in Advanced Melanoma

CHICAGO -- Two studies indicate that using investigative immunotherapy drugs improves survival and response in patients with metastatic melanoma, researchers said here.

ASCO: Antibody Adds 6 Weeks to Squamous NSCLC Survival

CHICAGO -- The novel anti-EGFR monoclonal antibody necitumumab modestly improved survival in squamous non-small cell lung cancer (NSCLC) in a pivotal trial, but many called the effect too small to count.

Small eGFR Drops May Predict Kidney Outcomes

Declines in estimated glomerular filtration rate (eGFR) smaller than those that currently attract clinical attention may help predict the risk of end-stage renal disease, researchers reported.

ASCO: Targeted Combo Extends PFS in Ovarian Ca

CHICAGO -- Progression-free survival almost doubled in women with platinum-sensitive relapsed ovarian cancer treated with two targeted drugs instead of one, investigators reported here.

ASCO: Ipilimumab Cuts Relapse but Safety Issues Remain

CHICAGO -- High-risk melanoma patients have a reduced level of relapse if they are taking the monoclonal antibody ipilimumab (Yervoy) when compared with placebo, researchers said here.

Dalfampridine: Not Just a Walking Aid

DALLAS -- Extended-release dalfampridine (Ampyra) is approved for boosting walking speed in multiple sclerosis patients, but its benefits extend to other aspects of physical function, according to a small study reported here.

CCSVI Practices Suboptimal but Patients Don't Mind

DALLAS -- Canadian multiple sclerosis patients who left the country to undergo the controversial procedure called chronic cerebrospinal venous insufficiency (CCSVI) often received poor pre- and postoperative care, but most were still relatively satisfied overall, a researcher reported here.

Real-Time Monitoring Cuts Cardiac Cath Radiation

LAS VEGAS -- A radiation detector that emits audible beeps might help interventional cardiologists and others in the cardiac catheterization laboratory reduce their exposure, researchers found.

Gastro Effects Dog Oral MS Drug Tecfidera

DALLAS -- Large proportions of patients starting on dimethyl fumarate (Tecfidera) for multiple sclerosis need additional medications to manage the drug's GI and other side effects, and a substantial minority ultimately find the drug intolerable.

Edible Dynamite, Cockney Rhyming Medical Slang: That's Improbable!

A weekly report from our friends at Improbable Research.

MS Bladder Problems Show Up Early and Often

Nearly 80% of multiple sclerosis patients in a large registry reported overactive bladder symptoms, and one-third of a separate cohort of newly diagnosed patients also showed urinary dysfunction, researchers reported here.

Richard III: Shakespeare Blew It

Shakespeare got almost everything wrong about Richard III鈥檚 physical appearance.

'This Page Left Intentionally Blank'

Blank pages in correspondence from insurance companies are just an emblem of the endless waste and inefficiencies built into our healthcare system, says internist Fred Pelzman.

More Brain Bleeds With Stroke Drug in 'Real World鈥�

BOSTON -- Intracerebral hemorrhage was more common among patients receiving tissue plasminogen activator (tPA) in the real world compared with those in a clinical trial, a small, single-center study showed.

How To Tell Fake Neck Pain From Real: The Pain Medicine News Report

A regular update on what鈥檚 new in surgery from our friends at Pain Medicine News.

War Wounds: Hearing Loss Tracks Gulf War Vets

Battlefield wounds are often both life-threatening and life-changing, but when hearing is the casualty, the wound is too often undiagnosed or untreated, but a new initiative is underway to change tackle the silent wounds of war.

Vaccines and Biologics: Questions Remain

Vaccinations for patients with autoimmune diseases -- specifically patients being treated with biologics -- bring with them a variety of issues, including disease-specific, medication-related, and vaccine-associated factors, researchers suggested.

Calif. Docs Among Top Billers for Complex Visits

Three California doctors are among the top five nationally in billing for the most complex office visits, according to data released by Medicare and analyzed by ProPublica and KQED.

E-cig Fumes Empower Bad Bugs

SAN DIEGO -- In laboratory studies, e-cigarette vapors appears to increase the aggressiveness of dangerous bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), researchers reported here.

AUA Offers Guidance for Kidney Stones

ORLANDO -- Treatment tailored to individual patient and stone characteristics provides the basis for an American Urological Association clinical guideline on medical management of kidney stones.

Enzyme Tx Durable for Peyronie's

ORLANDO -- Three-fourths of men with moderate to severe Peyronie's disease had meaningful improvement a year after treatment with an enzyme that dissolves scar tissue, investigators reported here.

Bone Drug No Help in Severe Gout

Bisphosphonate treatment failed to prevent the development of bone erosions in patients with longstanding tophaceous gout, a 2-year randomized study found.

Vitamin C May Save Newborn's Lungs When Mom Smokes

SAN DIEGO -- Damage to the lungs of babies born to mothers who smoked through pregnancy may be mitigated with vitamin C supplementation during gestation, researchers reported here.

Lung Foam Disappoints in COPD

SAN DIEGO -- A trial of hydrogel-based lung volume reduction therapy in patients with chronic obstructive pulmonary disease (COPD) complicated by emphysema failed to show consistent enough results and has been abandoned by the agent's developer, researchers said here.

鈥�

469

鈥�